XML 22 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash Equivalents, Marketable Securities and Equity Securities
9 Months Ended
Sep. 30, 2018
Cash Equivalents, Marketable Securities and Equity Securities  
Cash Equivalents, Marketable Securities and Equity Securities

3. Cash Equivalents, Marketable Securities and Equity Securities

 

Cash equivalents, marketable securities and equity securities consisted of the following at September 30, 2018 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

September 30, 2018

 

Cost

 

Gains

 

Losses

 

Value

Cash equivalents and marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

106,974

 

$

 —

 

$

 —

 

$

106,974

U.S. Treasuries

 

 

200,437

 

 

 —

 

 

(67)

 

 

200,370

Government agency securities

 

 

29,922

 

 

 —

 

 

(15)

 

 

29,907

Equity securities included in other non-current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate equity securities

 

 

3,667

 

 

 —

 

 

 —

 

 

3,667

Total

 

$

341,000

 

$

 —

 

$

(82)

 

$

340,918

 

Cash equivalents and marketable securities consisted of the following at December 31, 2017 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

December 31, 2017

 

Cost

 

Gains

 

Losses

 

Value

Cash equivalents and marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

134,635

 

$

 —

 

$

 —

 

$

134,635

U.S. Treasuries

 

 

135,601

 

 

 —

 

 

(47)

 

 

135,554

Government agency securities

 

 

58,979

 

 

 —

 

 

(29)

 

 

58,950

Total

 

$

329,215

 

$

 —

 

$

(76)

 

$

329,139

 

At September 30, 2018, the Company held 41 securities that were in an unrealized loss position. The aggregate fair value of securities held by the Company in an unrealized loss position for less than 12 months at September 30, 2018 was $230.3 million, and there were no securities held by the Company in an unrealized loss position for more than 12 months. Pursuant to the adoption of ASU 2016-01, the Company records changes in the fair value of its investments in corporate equity securities to “Other income (expense), net” in the Company’s condensed consolidated statements of operations. The Company records unrealized gains (losses) on available-for-sale debt securities as a component of accumulated other comprehensive income (loss) until such gains and losses are realized. 

 

As of September 30, 2018, the Company did not intend to sell, and would not be more likely than not required to sell, the debt securities in an unrealized loss position before recovery of their amortized cost bases. Furthermore, the Company has determined that there were no material changes in the credit risk of the debt securities. As a result, the Company determined it did not hold any marketable securities with any other-than-temporary impairment as of September 30, 2018.

 

There were no realized gains or losses on available-for-sale securities during the nine months ended September 30, 2018 or 2017.